Response to Comments: Immune Globulin

The provided document is a response-to-comments summary for LCD DL34007 (Immune Globulin) and contains only header/metadata without extractable coverage criteria. To determine specific indications, limitations, documentation requirements, and frequency limits for immune globulin coverage, the final LCD DL34007 must be consulted. Manual review of the full LCD and associated policy text is required to produce complete, actionable criteria.

"No specific coverage indications could be extracted from the provided text; the document is a response-to-comments summary referencing LCD DL34007 (Immune Globulin)."

Sign up to see full coverage criteria, indications, and limitations.